THNR Fees and Costs — Amplify Weight Loss Drug & Treatment ETF
Data updated: 2026-08-28
The net expense ratio is 0.59%. There are no sales loads or redemption fees. In fiscal 2024 the fund paid $815 in broker commissions, 0.0260% of average net assets, and portfolio turnover was 70%.
THNR Fees and Expenses
Annual operating expenses and sales charges of THNR. Prospectus, as of September 30, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.59% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.00% |
| Gross expense ratio | 0.59% |
| Fee waiver | — |
| Net expense ratio | 0.59% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | No |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
THNR Costs Over Time
On $10,000 invested in THNR, assuming 5% a year before costs, total costs come to $388 over 5 years, cutting the return by 0.65% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.59%) | $62 | $194 | $338 |
| Trading costs (broker commissions) | $3 | $9 | $15 |
| Lost growth on money paid in costs | $0 | $10 | $35 |
| Total costs | $65 | $213 | $388 |
| Value after costs | $10,435 | $11,364 | $12,375 |
| Impact on return, per year | 0.65% | 0.65% | 0.65% |
THNR Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending September 30, 2024.
- Explicit cost rate (commissions ÷ average net assets): 0.0260%
- Total broker commissions: $815
- Bought from dealers (principal trades, not a cost): —
- Portfolio turnover (prospectus): 70%
- Securities on loan, average value: $5K
- Net income from securities lending: $114 (0.004% of average net assets)
THNR Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| SUSQUEHANNA FINANCIAL GROUP, LLLP | $467 | 57.30% |
| BTIG LLC | $348 | 42.70% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.